Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Porcine endogenous retrovirus encodes xenoantigens involved in porcine cellular xenograft rejection by mice

Thumbnail Image

Date

2005

Authors

Simeonovic, Charmaine
Ziolkowski, Andrew
Popp, Sarah
Milburn, Peter J
Lynch, Celina-Anne
Hamilton, Peter
Harris, Karla
Brown, Debra
Bain, Simon
Wilson, James Dennis

Journal Title

Journal ISSN

Volume Title

Publisher

Lippincott Williams & Wilkins

Abstract

Background. Identification of the antigens that stimulate transplant rejection can help develop graft-specific antirejection strategies. The xenoantigens recognized during rejection of porcine cellular xenografts have not been clearly defined, but it has

Description

Keywords

Keywords: leukocyte antigen; animal cell; animal experiment; animal tissue; article; controlled study; graft rejection; human; human cell; immunization; kidney epithelium; male; morphometrics; mouse; nonhuman; peripheral lymphocyte; priority journal; Retrovirus; sw Porcine endogenous retrovirus; Rejection; Xenograft

Citation

URI

http://hdl.handle.net/1885/81226

Collections

ANU Research Publications

Source

Transplantation

Type

Journal article

Book Title

Entity type

Access Statement

License Rights

DOI

10.1097/01.TP.0000164316.55216.07

Restricted until

2037-12-31

Downloads

File
Description
01_Simeonovic_Porcine_endogenous_retrovirus_2005.pdf (3.03 MB)

DSpace software copyright © 2002-2026 LYRASIS